S. KOREA RECEIVES NEW BATCH OF ASTRAZENECA COVID-19 VACCINES

Highlights –

• S. Korea receives new batch of AstraZeneca COVID-19 vaccines.
• S. Korea received new 835,000 doses of AstraZeneca's COVID-19 vaccines.
• S. Korea vaccinated a total of 3.71 million people, or 7.2 percent of the populatio...

NEW DATA SHOWS ASTRAZENECA COVID-19 VACCINE IS 76% EFFECTIVE

Highlights

• The UK-based drugmaker AstraZeneca on Thursday said its vaccine was 76% effective at preventing symptomatic illness

• AstraZeneca on Thursday also reiterated the coronavirus developed by them along with the University of Oxford was 100% effective against...

AstraZeneca, JOHNSON & JOHNSON RESUME COVID VACCINE TRIALS IN U.S.

Highlights

• AstraZeneca said the Food and Drug Administration (FDA) today authorized the restart in the U.S., following the resumption of trials in other countries in recent weeks

• The drugmaker further said that the FDA reviewed all safety data from trials globall...

ASTRAZENECA US COVID-19 VACCINE TRIAL LIKELY TO RESUME THIS WEEK

Highlights

• Late-stage US trial of AstraZeneca's COVID-19 vaccine were put on hold since September 6 after a participant in the company’s UK trial fell ill with a suspiciously rare spinal inflammatory disorder known as transverse myelitis

• Sources claim t...

US LIKELY TO BUY ALL DOSES OF UK’S AstraZeneca-OXFORD COVID-19 VACCINE

Highlights

• The US President Donald Trump has directed defence and health chiefs to ensure that the US is the first in the list to get UK's COVID-19 vaccine currently developed by pharmaceutical company AstraZeneca along with the University of Oxford

• The Ameri...

FDA REPORTEDLY EXPANDING ITS INVESTIGATION OF ASTRAZENECA COVID-19 VACCINE TRIAL

Highlights

• Reports state that by expanding its probe into the unexplained illness, the FDA will be looking into trials conducted at earlier stages of similar vaccines developed by the same scientists

• One of the source has claimed that with this investigation, the...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO COMMENCE PHASE II TRIAL OF OXFORD VACCINE TODAY

According to the sources, the phase II human clinical trial of the Oxford COVID-19 vaccine candidate by the Serum Institute of India (SII), Pune will start from today. Bharati Vidyapeeth Medical College and Hospital in Pune is the site where this observer-blind, randomised controlled study to det...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK

Highlights

• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford

• On Monday, the national expert group on vacci...

COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE

Highlights

• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII

• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford

• Before starting the phase 3 tria...

MODERNA PROVIDES PROTECTION AGAINST COVID-19, REVEALED BY A STUDY CONDUCTED ON MONKEYS

Highlights:                  

• Moderna’s MRNA-1273 vaccine is able to induce a strong immunity against COVID-19 infection, a study conducted on monkeys proved this.

BILL GATES BACKED SK BIOSCIENCE CAN PRODUCE 200 MILLION

Highlights:

•     Bill Gates has funded SK BioScience a covid19 vaccine development worth $3.6 million in

•     SK Bioscience is also developing its candidates for COVID vaccines

Bill Gates foundation has now donated ...

JAPAN WANTS TO SECURE CORONAVIRUS VACCINE

HIGHLIGHTS

• Daiichi Sankyo is talking to AstraZeneca to secure Japan supplies of a potential coronavirus vaccine.
• The vaccine is called AZD1222.

Japanese pharmaceutical company Daiichi Sankyo is in discussions with British pharmaceuti...

CORONAVIRUS VACCINE DEVELOPED AT OXFORD UNIVERSITY SHOWS PROMISING SIGNS

Highlights

• The vaccine which was tested on a group of monkeys was successful in preventing damage to the lungs

• This vaccine stops the virus from doubling in lungs, though it still keep replicating itself in the nose

According to a report, a potential co...

China publishes the most research papers on AI, but has no effect, report says

According to conventional wisdom, China is about to become the world leader in artificial intelligence.

But the Chinese representative in the Oxford University Future for Humanity Institute's Center for the Governance of AI, Jeffrey Ding, takes a very different view: Chinese mastery...

Letter by Ruth van Heyningen

Upon attending the Nuffield Laboratory of Ophthalmology at Oxford University in 1951, Ruth van Heyningen, who died at the age of 101, was a pioneering researcher of ophthalmic biochemistry. Tony and Ruth wrote together a key book, Biochemistry of the Eye, which Ruth said later included nearly eve...

Commencement of partnership between Evotec, Oxford University, and Sensyne health

There has been the commencement of a new long-term partnership of the Evotec from Germany with Oxford University and AI tech company’ Sensyne Health’, which is a British firm, for the translation of research into new firms which is devoted to digital health, data-driven drug discovery & establis...